All Stories

  1. Signs o’ the Times. The Quiet Revolution of Molecular Pathology in Gynecologic Oncology: A Narrative Review
  2. Sialic Acids in Kidney Disease: Immune Regulation, Complement Activation and Glomerular Injury
  3. Immune Checkpoint Landscape in Pediatric Uveal Melanoma
  4. Tumor Microenvironment and Immune Response Against Wilms Tumor: Evasion Mechanisms and Implications for Immunotherapeutic Approaches
  5. The Role of Fetal Autopsy in 2025: A Cornerstone in Fetal Loss Management and Genomic Medicine
  6. Integrating Molecular Diagnostics into Cervical Cancer Screening: A Workflow Using FFPE Tissue Samples
  7. Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review
  8. Primary Lung Tumors in Children: Insights from a Single-Center Case Series
  9. Evaluating HPV Viral Load and Multiple Infections for Enhanced Cervical Cancer Risk-Based Assessment
  10. AntiCD44 antibody-conjugated gold nanoparticles for targeted photothermal therapy of endometriotic cells
  11. Multiple Tumors in a Patient with Interleukin-2-Inducible T-Cell Kinase Deficiency: A Case Report
  12. Shiga toxin-producing Escherichia coli infection as a precipitating factor for atypical hemolytic-uremic syndrome
  13. Nerve Sheath Myxoma in Pregnancy: A Case Report
  14. Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
  15. Frozen Section of Placental Membranes and Umbilical Cord: A Valid Diagnostic Tool for Early-Onset Neonatal Sepsis Management
  16. Advancements in Gynecologic Pathology: A Molecular, Digital, and Biobanking Perspective
  17. From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models
  18. Hemostatic Profile of Intrauterine Growth-Restricted Neonates: Assessment with the Use of NATEM Assay in Cord Blood Samples
  19. The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis
  20. Outpatient surgery at the Pediatric Dermatology Unit
  21. The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition
  22. Bovine Papillomavirus Type 1 Infection in an Equine Congenital Papilloma
  23. The Advantages of NGS Molecular Classification in Endometrial Cancer Diagnosis
  24. Paediatric Spitzoid Neoplasms: 10-Year Retrospective Study Characterizing Histological, Clinical, Dermoscopic Presentation and FISH Test Results
  25. Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?
  26. POS0933 NAILFOLD VIDEOCAPILLAROSCOPY AS A POSSIBLE BIOMARKER TO DETECT ABERRANT PLACENTAL MICROCIRCULATION IN PREGNANT WOMEN: A PILOT STUDY
  27. Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
  28. Screening of Precancerous Lesions in Women with Human Papillomavirus (HPV) Infection by Molecular Typing and MicroRNA Analysis
  29. The nano-revolution in the diagnosis and treatment of endometriosis
  30. Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
  31. L1CAM variants cause two distinct imaging phenotypes on fetal MRI
  32. 33rd European Congress of Pathology – Abstracts
  33. A prospective study comparing rectal water contrast‐transvaginal ultrasonography with sonovaginography for the diagnosis of deep posterior endometriosis
  34. HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL PROGNOSTIC FACTORS IN HIGH-GRADE NON-ENDOMETRIOID CARCINOMAS OF THE ENDOMETRIUM (HG-NECs). IS IT POSSIBLE TO IDENTIFY SUB-GROUPS AT INCREASED RISK?
  35. New Insights into Endometrial Cancer
  36. Neoadjuvant imatinib as treatment preceding surgery for vulvar dermatofibrosarcoma protuberans
  37. SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice
  38. Evidence, evolution and pattern of contractile elements in villous vascular walls and stroma of human placentas of premature infants of different gestational ages. An immuno-morphologic comparative study
  39. Efficacy and safety of prolonged-release hyaluronic acid derivative vaginal application in the postpartum period: a prospective randomised clinical trial
  40. Multivariate Analysis Of Histopathological And Immunohistochemical Prognostic Factors In Endometrial Carcinoma. A Retrospective Pilot Study Of An Italian Regional Referral Center
  41. Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression
  42. Nasal Septum Warthin's Tumor: A Unique Case Report and Review of the Literature
  43. MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma
  44. Female Malignancies and Immunotherapy: What’s New?
  45. Concurrent benign tertiary syphilis and asymptomatic neurosyphilis in an immunocompetent patient
  46. Implementing NGS-based BRCA tumour tissue testing in FFPE ovarian carcinoma specimens: hints from a real-life experience within the framework of expert recommendations
  47. BOWEL OCCULT MICROSCOPIC ENDOMETRIOSIS IN RESECTION MARGINS IN DEEP COLORECTAL ENDOMETRIOSIS SPECIMENS HAS NO IMPACT ON THE LONG-TERM RISK OF RECURRENCE
  48. 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study
  49. PERSISTENCE OF RECTAL ENDOMETRIOSIS FOLLOWING LAPAROSCOPIC SHAVING OF RECTOVAGINAL NODULES INFILTRATING THE RECTUM
  50. Abstract CT075: Fasting-mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects
  51. Fasting-mimicking diet and hormone therapy induce breast cancer regression
  52. P53 staining index and zonal staining patterns in actinic keratoses
  53. Steroids receptors immunohistochemical expression in different sites of endometriosis
  54. Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19
  55. Magnetic Resonance Rectal Enema Versus Computed Tomographic Colonography in the Diagnosis of Rectosigmoid Endometriosis
  56. A Prospective Study Comparing Three-Dimensional Rectal Water Contrast Transvaginal Ultrasonography and Computed Tomographic Colonography in the Diagnosis of Rectosigmoid Endometriosis
  57. Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy
  58. Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3
  59. Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs
  60. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant
  61. Atomic force microscopy: a promising aid in diagnosis of uterine smooth muscle neoplasms
  62. Circulating placental growth factor (PLGF) concentration in pregnant women with endometriosis: a case-control study
  63. Dienogest for pain and intestinal symptoms caused by rectosigmoid endometriosis: prospective cohort study
  64. Magnetic resonance with gel enema (MR-e) versus computed tomographic colonography (CTC) for diagnosing rectosigmoid endometriosis
  65. Preoperative treatment with leuprolide acetate and ulipristal acetate before outpatient hysteroscopic myomectomy: prospective comparative study
  66. Total disc replacement for lumbar degenerative disc disease: single centre 20 years experience
  67. What can we learn from the histopathology of retained placenta? A 15-year experience at a regional referral center
  68. Pathophysiology of pain in patients with peritoneal endometriosis
  69. Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas
  70. Transvaginal sonography with vs without bowel preparation in diagnosis of rectosigmoid endometriosis: prospective study
  71. Giant Hepatic Hemangioma and Placental Chorangiosis: A Unique Case of Stillbirth?
  72. Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
  73. Ulipristal Acetate before Hysteroscopic and Laparoscopic Surgery for Uterine Myomas: Help or Hindrance?
  74. Influence of adenomyosis on pregnancy and perinatal outcomes in women with endometriosis
  75. Does Bowel Preparation Improve the Performance of Rectal Water Contrast Transvaginal Ultrasonography in Diagnosing Rectosigmoid Endometriosis?
  76. Ureteral endometriosis: a systematic review of epidemiology, pathogenesis, diagnosis, treatment, risk of malignant transformation and fertility
  77. A Survey on the Knowledge and Attitudes of Italian Medical Students toward Body Donation: Ethical and Scientific Considerations
  78. Peritoneal carcinomatosis from ovarian paraganglioma: Report of a rare case and systematic review of the literature
  79. Inflammatory Response Modulation through a PPARγ Agonist during Surgically Induced Visceral Ischemia in an Animal Model
  80. Changes in Androgen Receptor Expression as a Molecular Marker of Progression from Normal Epithelium to Invasive Cancer in Elderly Patients with Penile Squamous Cell Carcinoma
  81. Kidney Ultrastructure by Atomic Force Microscopy Imaging Directly From Formalin Fixed-Paraffin Embedded Biopsy: Is This a Dream Come True?
  82. Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids
  83. PERITONEAL CARCINOMATOSIS FROM PRIMARY MALIGNANT OVARIAN PARAGANGLIOMA: A CHALLENGING MANAGEMENT OF AN EXTREMELY RARE CASE
  84. Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer
  85. Zinner Syndrome: A Diagnostic Challenge. The Aid of Morphology, Embryology, and Immunohistochemistry
  86. Cutaneous metastasis from vulvar squamous cell carcinoma: a rare occurrence that should not be forgotten
  87. Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis
  88. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair
  89. Virtopsy in conjoined ischiopagus twins
  90. Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model
  91. Computed tomographic colonographyvsrectal water- contrast transvaginal sonography in diagnosis of rectosigmoid endometriosis: a pilot study
  92. Magnetic resonance enemavsrectal water-contrast transvaginal sonography in diagnosis of rectosigmoid endometriosis
  93. Spontaneous fertility after expectant or surgical management of rectovaginal endometriosis in women with or without ovarian endometrioma: a retrospective analysis
  94. Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report
  95. Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer
  96. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study
  97. A case of thyroid cancer on the track of the radiofrequency electrode 30 months after percutaneous ablation
  98. Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study.
  99. Incidental Diagnosis of Giant Cell Tumor After Urachal Remnant Removal in a Thalassemic Child
  100. Interobserver reproducibility in pathologist interpretation of columnar-lined esophagus
  101. Excision of Ectopic Adrenocortical Tissue During Laparoscopy for Pelvic Endometriosis
  102. Computed Tomographic Colonography in the Diagnosis of Recto-Sigmoid Endometriosis: A Pilot Study
  103. Real-Time Transvaginal Elastography of Recto-Sigmoid Endometriotic Nodules: Correlation With Symptoms and Histology
  104. Advances in pharmacotherapy for treating endometriosis
  105. OP03.01: Elastographic features of ovarian dermoid cysts
  106. Spontaneous Uroperitoneum and Preterm Delivery in a Patient With Bladder Endometriosis
  107. Atypical Cellular Chorangioma
  108. Intestinal Endometriosis: Mimicker of Inflammatory Bowel Disease?
  109. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery
  110. Human Papillomavirus (HPV) Infection in Squamous Cell Carcinomas Arising From the Oropharynx: Detection of HPV DNA and p16 Immunohistochemistry as Diagnostic and Prognostic Indicators—A Pilot Study
  111. Post-partum hemorrhage and malpractice claims: What can we learn from the findings of placental examination and endometrial curettage? A retrospective analysis of surgical pathology reports
  112. Secondary malignancies of the uterine cervix: a potential diagnostic pitfall
  113. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer
  114. Expression of the Glioma-Associated Oncogene Homolog 1 (Gli1) in Advanced Serous Ovarian Cancer Is Associated with Unfavorable Overall Survival
  115. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
  116. BRAF(V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma
  117. Clinicopathologic and Immunohistochemical Features of Ovarian Clear Cell Carcinomas in Comparison With Type I and Type II Tumors
  118. O753 SECONDARY MALIGNANCY TO THE UTERINE CERVIX: TOO UNCOMMON TO BE CONSIDERED? THE ROLE OF THE PATHOLOGIST
  119. Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study
  120. Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models
  121. Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer
  122. Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women
  123. Morphological and immunocytochemical diagnosis of thyroiditis: Comparison between conventional and liquid-based cytology
  124. Free Papers
  125. Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size
  126. Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations
  127. Borderline Mucinous Endocervical Tumor as a Link Between the Endometriotic Cyst and Ovarian Primary Squamous Cell Carcinoma
  128. Ovarian cancer arising in endometrioid cysts: ultrasound findings
  129. Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma
  130. Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical study
  131. The Decrease of Serum Levels of Human Neutrophil Alpha-Defensins Parallels with the Surgery-Induced Amelioration of NASH in Obesity
  132. Morphology and Immunophenotyping of a Monolateral Ovotestis in a 46,XderY/45,X Mosaic Individual With Ambiguous Genitalia
  133. Clinical Performance of Human Papillomavirus E6 and E7 mRNA Testing for High-Grade Lesions of the Cervix
  134. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease
  135. Colonic Carcinoma Metastatic to the Endometrium
  136. RNA (E6 and E7) Assays versus DNA (E6 and E7) Assays for Risk Evaluation for Women Infected with Human Papillomavirus
  137. Plantar Melanoma That Mimics Melanocytic Nevi: A Report of 4 Cases With Lymph Node Metastases and With Review of Positive and Negative Controls
  138. Accuracy of Papanicolaou Smears in Cervical Cancer Patients Treated With Radiochemotherapy Followed by Radical Surgery
  139. Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease
  140. Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas
  141. NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
  142. PA.92 A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
  143. Morphological Effects of Radiochemotherapy on Cervical Carcinoma
  144. Should a renal biopsy be performed at the first relapse of ‘clinical nephrotic syndrome’?
  145. Ovarian endomyometrioma with atypias: description of a case
  146. Endometrial carcinoma recurring as carcinosarcoma: Report of two cases
  147. Glassy cell carcinoma of the endometrium: A case report and review of the literature
  148. Ovarian serous carcinoma presenting with mediastinal lymphadenopathy 20 months before the intraabdominal mass: Role of immunohistochemistry
  149. Solitary choroid plexus tuberculoma in an adult patient
  150. Celecoxib Up-Regulates the Expression of the   Chain of T Cell Receptor Complex in Tumor-Infiltrating Lymphocytes in Human Cervical Cancer
  151. Hepatocyte growth factor and transforming growth factor β1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis
  152. Endometrioid adenocarcinoma with squamous differentiation arising from ureteral endometriosis in a patient with no history of gonadal endometriosis